
Antibiotic cycling affects resistance evolution independently of collateral sensitivity
- Author
- Pauline Brepoels, Kenny Appermans, Camilo Andrés Pérez Romero (UGent) , Bram Lories, Kathleen Marchal (UGent) and Hans P. Steenackers
- Organization
- Project
-
- Forwarding precision oncology by integrating cohort-derived molecular and clinical information.
- High resolution networks for the analysis of genetic rewiring in cancer
- The importance of epistasis and network rewiring in determining the adaptive outcome of bacterial populations subjected to antibiotic gradients
- Abstract
- Antibiotic cycling has been proposed as a promising approach to slow down resistance evolution against currently employed antibiotics. It remains unclear, however, to which extent the decreased resistance evolution is the result of collateral sensitivity, an evolutionary trade-off where resistance to one antibiotic enhances the sensitivity to the second, or due to additional effects of the evolved genetic background, in which mutations accumulated during treatment with a first antibiotic alter the emergence and spread of resistance against a second antibiotic via other mechanisms. Also, the influence of antibiotic exposure patterns on the outcome of drug cycling is unknown. Here, we systematically assessed the effects of the evolved genetic background by focusing on the first switch between two antibiotics against Salmonella Typhimurium, with cefotaxime fixed as the first and a broad variety of other drugs as the second antibiotic. By normalizing the antibiotic concentrations to eliminate the effects of collateral sensitivity, we demonstrated a clear contribution of the evolved genetic background beyond collateral sensitivity, which either enhanced or reduced the adaptive potential depending on the specific drug combination. We further demonstrated that the gradient strength with which cefotaxime was applied affected both cefotaxime resistance evolution and adaptation to second antibiotics, an effect that was associated with higher levels of clonal interference and reduced cost of resistance in populations evolved under weaker cefotaxime gradients. Overall, our work highlights that drug cycling can affect resistance evolution independently of collateral sensitivity, in a manner that is contingent on the antibiotic exposure pattern.
- Keywords
- MEDIATED MULTIDRUG-RESISTANCE, ESCHERICHIA-COLI, HISTIDINE KINASE, CORE, DOMAIN, BINDING, PATHS, ACRB, ENVZ, PHARMACODYNAMICS, TYPHIMURIUM
Downloads
-
8243.pdf
- full text (Published version)
- |
- open access
- |
- |
- 1.59 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-01GQPTQFN9VR413822QHR2QW30
- MLA
- Brepoels, Pauline, et al. “Antibiotic Cycling Affects Resistance Evolution Independently of Collateral Sensitivity.” MOLECULAR BIOLOGY AND EVOLUTION, vol. 39, no. 12, 2022, doi:10.1093/molbev/msac257.
- APA
- Brepoels, P., Appermans, K., Pérez Romero, C. A., Lories, B., Marchal, K., & Steenackers, H. P. (2022). Antibiotic cycling affects resistance evolution independently of collateral sensitivity. MOLECULAR BIOLOGY AND EVOLUTION, 39(12). https://doi.org/10.1093/molbev/msac257
- Chicago author-date
- Brepoels, Pauline, Kenny Appermans, Camilo Andrés Pérez Romero, Bram Lories, Kathleen Marchal, and Hans P. Steenackers. 2022. “Antibiotic Cycling Affects Resistance Evolution Independently of Collateral Sensitivity.” MOLECULAR BIOLOGY AND EVOLUTION 39 (12). https://doi.org/10.1093/molbev/msac257.
- Chicago author-date (all authors)
- Brepoels, Pauline, Kenny Appermans, Camilo Andrés Pérez Romero, Bram Lories, Kathleen Marchal, and Hans P. Steenackers. 2022. “Antibiotic Cycling Affects Resistance Evolution Independently of Collateral Sensitivity.” MOLECULAR BIOLOGY AND EVOLUTION 39 (12). doi:10.1093/molbev/msac257.
- Vancouver
- 1.Brepoels P, Appermans K, Pérez Romero CA, Lories B, Marchal K, Steenackers HP. Antibiotic cycling affects resistance evolution independently of collateral sensitivity. MOLECULAR BIOLOGY AND EVOLUTION. 2022;39(12).
- IEEE
- [1]P. Brepoels, K. Appermans, C. A. Pérez Romero, B. Lories, K. Marchal, and H. P. Steenackers, “Antibiotic cycling affects resistance evolution independently of collateral sensitivity,” MOLECULAR BIOLOGY AND EVOLUTION, vol. 39, no. 12, 2022.
@article{01GQPTQFN9VR413822QHR2QW30, abstract = {{Antibiotic cycling has been proposed as a promising approach to slow down resistance evolution against currently employed antibiotics. It remains unclear, however, to which extent the decreased resistance evolution is the result of collateral sensitivity, an evolutionary trade-off where resistance to one antibiotic enhances the sensitivity to the second, or due to additional effects of the evolved genetic background, in which mutations accumulated during treatment with a first antibiotic alter the emergence and spread of resistance against a second antibiotic via other mechanisms. Also, the influence of antibiotic exposure patterns on the outcome of drug cycling is unknown. Here, we systematically assessed the effects of the evolved genetic background by focusing on the first switch between two antibiotics against Salmonella Typhimurium, with cefotaxime fixed as the first and a broad variety of other drugs as the second antibiotic. By normalizing the antibiotic concentrations to eliminate the effects of collateral sensitivity, we demonstrated a clear contribution of the evolved genetic background beyond collateral sensitivity, which either enhanced or reduced the adaptive potential depending on the specific drug combination. We further demonstrated that the gradient strength with which cefotaxime was applied affected both cefotaxime resistance evolution and adaptation to second antibiotics, an effect that was associated with higher levels of clonal interference and reduced cost of resistance in populations evolved under weaker cefotaxime gradients. Overall, our work highlights that drug cycling can affect resistance evolution independently of collateral sensitivity, in a manner that is contingent on the antibiotic exposure pattern.}}, articleno = {{msac257}}, author = {{Brepoels, Pauline and Appermans, Kenny and Pérez Romero, Camilo Andrés and Lories, Bram and Marchal, Kathleen and Steenackers, Hans P.}}, issn = {{0737-4038}}, journal = {{MOLECULAR BIOLOGY AND EVOLUTION}}, keywords = {{MEDIATED MULTIDRUG-RESISTANCE,ESCHERICHIA-COLI,HISTIDINE KINASE,CORE,DOMAIN,BINDING,PATHS,ACRB,ENVZ,PHARMACODYNAMICS,TYPHIMURIUM}}, language = {{eng}}, number = {{12}}, pages = {{21}}, title = {{Antibiotic cycling affects resistance evolution independently of collateral sensitivity}}, url = {{http://doi.org/10.1093/molbev/msac257}}, volume = {{39}}, year = {{2022}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: